BTT-3033

MedChem Express

BTT-3033 [1259028-99-3]

10

1259028-99-3

Research Use Only

99.22

C23H20FN5O3S

465.50

BTT-3033 is an orally active conformation-selective inhibitor of alpha2beta1 ( EC50 : 130 nM) by binding to the alpha2I domain. BTT-3033 inhibits platelet binding to collagen I and cell proliferation, and induces cell apoptosis . BTT-3033 can be used in the research of prostate cancer, inflammation and cardiovascular disease [1] [2] [4] .

O=C(NC1=CC=C(N(S(=O)(C2=CN(C3=CC=C(C=C3)F)N=C2)=O)C)C=C1)NC4=CC=CC=C4

-20°C

12352200